BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35292799)

  • 21. Multimodality Imaging for the Assessment of Mitral Valve Disease.
    Kim DH
    Cardiol Clin; 2021 May; 39(2):243-253. PubMed ID: 33894938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of cardiac computed tomographic angiography to transesophageal echocardiography for evaluation of patients with native valvular heart disease.
    LaBounty TM; Glasofer S; Devereux RB; Lin FY; Weinsaft JW; Min JK
    Am J Cardiol; 2009 Nov; 104(10):1421-8. PubMed ID: 19892062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal use of echocardiography in valvular heart disease evaluation.
    Siegel RJ; Luo H; Makar M; Beigel R
    Heart; 2015 Jun; 101(12):977-86. PubMed ID: 25801000
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence and severity of Doppler-detected valvular regurgitation and estimation of right-sided cardiac pressures in patients with normal two-dimensional echocardiograms.
    Lavie CJ; Hebert K; Cassidy M
    Chest; 1993 Jan; 103(1):226-31. PubMed ID: 8417884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Valvular insufficiency in dilated cardiomyopathy diagnosed by color Doppler echocardiography].
    Díaz RA; Nihoyannopoulos P; Oakley CM
    Rev Med Chil; 1989 Nov; 117(11):1232-5. PubMed ID: 2519797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Cardiovascular Magnetic Resonance in Native Valvular Regurgitation: A Comprehensive Review of Protocols, Grading of Severity, and Prediction of Valve Surgery.
    Vermes E; Iacuzio L; Levy F; Bohbot Y; Renard C; Gerber B; Maréchaux S; Tribouilloy C
    Front Cardiovasc Med; 2022; 9():881141. PubMed ID: 35872899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK.
    Marciniak A; Glover K; Sharma R
    BMJ Open; 2017 Jan; 7(1):e012240. PubMed ID: 28131996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of Doppler echocardiography in the management of patients with valvular heart disease: analysis of one year of clinical practice.
    van den Brink RB; Verheul HA; Hoedemaker G; Düren DR; Reedijk M; Visser CA; Dunning AJ
    J Am Soc Echocardiogr; 1991; 4(2):109-20. PubMed ID: 2036223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
    Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Echocardiographic versus histologic findings in Marfan syndrome.
    Gu X; He Y; Li Z; Han J; Chen J; Nixon JV
    Tex Heart Inst J; 2015 Feb; 42(1):30-4. PubMed ID: 25873795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regurgitant valvular disease prevalence and progression found on echocardiogram in military aviators.
    Davis SM; Davenport ED; Haynes JT; Alvarado RL
    Aviat Space Environ Med; 2014 Oct; 85(10):1013-8. PubMed ID: 25245901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development of real-time two-dimensional Doppler echocardiography and its clinical significance in acquired valvular diseases. With special reference to the evaluation of valvular regurgitation.
    Omoto R; Yokote Y; Takamoto S; Kyo S; Ueda K; Asano H; Namekawa K; Kasai C; Kondo Y; Koyano A
    Jpn Heart J; 1984 May; 25(3):325-40. PubMed ID: 6471389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doppler echocardiographic evaluation of valve regurgitation in healthy volunteers.
    Jobic Y; Slama M; Tribouilloy C; Lan Cheong Wah L; Choquet D; Boschat J; Penther P; Lesbre JP
    Br Heart J; 1993 Feb; 69(2):109-13. PubMed ID: 8435234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical update in cardiac imaging including echocardiography.
    Ramakrishna H; Feinglass N; Augoustides JG
    J Cardiothorac Vasc Anesth; 2010 Apr; 24(2):371-8. PubMed ID: 20167505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of valvular regurgitation by transesophageal echocardiography.
    Rosenthal SM; Nanda NC
    J Invasive Cardiol; 1992 Sep; 4(7):366-72. PubMed ID: 10147823
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of valvular regurgitation with Doppler echocardiography.
    Nagueh SF
    Cardiol Clin; 1998 Aug; 16(3):405-19, vii. PubMed ID: 9742321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
    Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
    Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow assessment through four heart valves simultaneously using 3-dimensional 3-directional velocity-encoded magnetic resonance imaging with retrospective valve tracking in healthy volunteers and patients with valvular regurgitation.
    Roes SD; Hammer S; van der Geest RJ; Marsan NA; Bax JJ; Lamb HJ; Reiber JH; de Roos A; Westenberg JJ
    Invest Radiol; 2009 Oct; 44(10):669-75. PubMed ID: 19724233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biventricular MR volumetric analysis and MR flow quantification in the ascending aorta and pulmonary trunk for quantification of valvular regurgitation].
    Rominger MB; Kluge A; Bachmann GF
    Rofo; 2004 Mar; 176(3):342-9. PubMed ID: 15026947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Doppler echocardiography in the evaluation of valvular regurgitations].
    Asín Cardiel E; Moya Mur JL
    Rev Esp Cardiol; 1994; 47 Suppl 4():34-45. PubMed ID: 7863085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.